The FDA-approved smoking cessation pill, varenicline, has emerged as a groundbreaking solution in the battle against nicotine addiction, particularly among the youth.A recent clinical trial conducted by researchers at Mass General Brigham revealed that young adults who utilized varenicline to quit vaping were over three times more successful than those relying solely on behavioral therapy.